Omadacycline Enters the Ring: A New Antimicrobial Contender

Omadacycline is a novel aminomethylcycline approved for the treatment of community‐acquired bacterial pneumonia and acute bacterial skin and skin structure infections. This article reviews existing data pertaining to the biochemistry, mechanism of action, pharmacokinetics/pharmacodynamics, in vitro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmacotherapy
Asıl Yazarlar: Barber, Katie E., Bell, Alison M., Wingler, Mary Joyce B., Wagner, Jamie L., Stover, Kayla R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Focus on Antimicrobial Therapy
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587716/
https://ncbi.nlm.nih.gov/pubmed/30290000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.2185
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller